Level Brands (LEVB) Pitch Deck (2019): 19-Slide Breakdown

This 2019 investor deck from Level Brands (LEVB) serves as a transition document following the company's December 2018 acquisition of cbdMD. Unlike a typical startup seed deck, this is a public company presentation designed to justify a 'transformational acquisition' to shareholders and the broader market. The deck highlights a shift from general brand licensing to a focused play in the then-booming CBD industry. With 71% insider ownership and a $82M market cap at the time of the deck, the narrative leans heavily on the celebrity branding of Kathy Ireland and aggressive marketing milestones,…

Key takeaways

• The company completed its IPO on the NYSE American in November 2017, as stated on slide 3.
• A transformational acquisition of cbdMD was completed in December 2018, shifting the company's primary goal to becoming the #1 CBD company (slide 3).
• The product line is extensive, featuring 78 SKUs including 24 oils, 18 topicals, and 13 pet products (slide 11).
• Marketing is a core pillar, highlighted by a Times Square advertisement on December 31, 2018 (slide 15).
• Financials show 2018 pro-forma sales of $15.9M and a cash position of $4.3M as of September 30, 2018 (slide 17).
• The acquisition agreement includes aggressive revenue earnout hurdles, targeting $300M in total revenue by 2023 (slide 17).
• Insider ownership is notably high at 71%, indicating significant founder/management skin in the game (slide 17).
• The deck omits a traditional 'Problem' slide, assuming the audience is already sold on the growth of the CBD market (slide 7).

Frequently asked questions

What was the primary purpose of this deck?

This deck was created for investors following Level Brands' acquisition of cbdMD. It aims to rebrand the company in the eyes of the public market, moving from a general licensing firm to a specialized CBD powerhouse. It focuses on the scale of the new product line and the marketing reach already achieved to justify the $82M market capitalization.

How does the company leverage celebrity involvement?

Slide 3 and 5 highlight that the company was co-founded by Kathy Ireland. It uses her 'Supermodel Supermogul' Forbes status to lend credibility to their 'kathy ireland Health & Wellness' brand. This suggests a strategy of using established celebrity trust to bypass the typical trust-building phase required for new consumer health products.

What are the specific financial targets mentioned?

Slide 17 outlines 'Revenue Earnout Hurdles.' To trigger share releases, the company aimed for $20M in revenue in 2019, $40M in 2020, $80M in 2021-2022, and $160M in 2022-2023. This total target of $300M provides a clear roadmap for what management considers 'success' for the acquisition.

What is the distribution strategy for the CBD products?

According to slide 3, the products were available in 700 retail outlets in the US as of January 2019, alongside an 'expanding e-commerce channel.' Slide 9 reinforces this by stating their goal is to market CBD products 'for the masses, not the few,' implying a high-volume, broad-retail approach.

What critical startup metrics are missing from this deck?

Because this is a public company deck, it lacks typical venture metrics like Customer Acquisition Cost (CAC), Lifetime Value (LTV), or a detailed 'Burn Rate.' It also lacks a slide dedicated to the competitive landscape, which is unusual for a sector as crowded as CBD was in 2019.

Level Brands (LEVB) pitch deck: the facts

Company

Level Brands (LEVB)

Year

2019

Stage

Public (NYSE American)

Slides

19

Sector

Consumer Products / CBD

Deck type

Investor Update / Acquisition Summary

Outcome

Post-Acquisition Strategic Pivot

Headquarters

USA

Level Brands (LEVB) pitch deck PDF

The full Level Brands (LEVB) deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the Level Brands (later cbdMD, Inc., NYSE American: LEVB → YCBD) pitch deck was used for

This is Level Brands’ January 2019 investor presentation, prepared shortly after closing its all‑stock acquisition of Cure Based Development, LLC, owner of the cbdMD consumer CBD brand, on December 20, 2018. At this point Level Brands was already publicly listed on the NYSE American under ticker LEVB following a 2017 IPO and was pivoting from a Kathy Ireland–anchored brand‑licensing model into a focused CBD consumer products company built around cbdMD. The deck is positioned as a corporate/investor update for public‑market and institutional investors rather than a private venture round, emphasizing the cbdMD acquisition structure, brand portfolio, and CBD market growth rather than a discrete primary capital raise.

Business model: Owner and marketer of consumer cannabidiol (CBD) brands, primarily the cbdMD line of CBD products for humans and pets, sold through e‑commerce and retail channels.

Year

2019

Headquarters

Charlotte, North Carolina, United States.

Industry

Consumer packaged goods / Cannabidiol (CBD) products.

Round: Public company corporate/investor update; no discrete primary capital round disclosed in connection with this deck.

What happened after the Level Brands (later cbdMD, Inc., NYSE American: LEVB → YCBD) deck

The January 2019 Level Brands deck marked the company’s transition from a Kathy‑Ireland–linked licensing operator into a CBD consumer products platform built around cbdMD, executed via an all‑stock acquisition of Cure Based Development; the combined company later rebranded as cbdMD, Inc. and pursued growth in the U.S. CBD market while managing dilution, regulatory uncertainty, and profitability ch

• December 3, 2018: Level Brands signs a Merger Agreement to acquire Cure Based Development, LLC, owner of cbdMD, through
• December 20, 2018: The mergers with Cure Based Development close, and Level Brands becomes the owner of the cbdMD brand.
• Early 2019: Level Brands issues the January 2019 investor deck to explain the cbdMD acquisition and strategic pivot.
• 2019: The company changes its corporate name from Level Brands, Inc. to cbdMD, Inc., reflecting its focus on the cbdMD c
• Subsequent filings and reports indicate strong sales growth but also highlight ongoing losses and going‑concern risks as

What the Level Brands (later cbdMD, Inc., NYSE American: LEVB → YCBD) deck got right

• Completed cbdMD acquisition underpins the pivot story. The deck highlights a defined strategic pivot backed by a completed transaction: an executed Merger Agreement and closing of the all‑stock acquisition of Cure Based Development / cbdMD in December 2018, giving investors clarity that the core CBD platform is already under corporate control rather than hypothetical.
• Clear product differentiation and portfolio breadth. Investor materials emphasize cbdMD’s broad product line (gummies, tinctures, topicals, bath bombs, oils, pet products) and its positioning around domestically sourced, pesticide‑free hemp, seed‑to‑sale control, and 0% THC, providing a concrete differentiation narrative versus lower‑quality imported CBD oils.
• Blended leadership and board with brand and operating experience. The leadership slide showcases a combined team including Kathy Ireland as Chief Brand Strategist and Chairman Emeritus, Level Brands’ CEO Martin Sumichrast and CFO/COO Mark Elliott, alongside cbdMD founders Scott Coffman and Caryn Dunayer, plus a board with figures such as Anthony K. Shriver and Bakari Sellers, signaling a mix of branding, operational, and governance experience.
• Incentive‑aligned, cash‑conserving deal structure. By structuring the cbdMD deal as an all‑stock transaction with clearly disclosed share tranches and vesting schedules, the company aligns cbdMD owners’ incentives with long‑term equity performance while conserving cash, an important consideration for a small public issuer entering a capital‑intensive growth phase.
• Compelling macro tailwind framing for CBD market entry. The deck situates the cbdMD pivot within a rapidly expanding U.S. CBD market, referencing external projections that the sector could reach tens of billions of dollars in size, which, if combined with cbdMD’s early‑mover positioning and rapid workforce expansion, supports a credible growth story.
• Emphasis on quality control and domestic supply chain. Slides stressing seed‑to‑sale processes and the avoidance of pesticides and imported low‑quality hemp, reinforced by disclosures describing domestic production, indicate that the company is attuned to quality and supply‑chain concerns that sophisticated investors watch closely in CBD.

What could have been stronger

• Limited financial transparency in the deck itself. The January 2019 deck, as reflected in the OCR excerpts and companion presentations, emphasizes brand story, leadership, and market opportunity but does not clearly disclose historical financial metrics such as revenue, gross margin, or profitability for either Level Brands’ legacy licensing operations or cbdMD’s CBD product sales, forcing investors to rely on separate filings to assess financial performance.
• Operational details on supply chain and capacity are sparse. While the deck stresses cbdMD’s differentiation (organic processes, domestic sourcing, 0% THC, broad‑spectrum innovation), it does not provide quantified data on production capacity, supply contracts, or quality metrics, leaving key operational risks around hemp sourcing and manufacturing scalability to be inferred from SEC filings rather than directly addressed in the slides.
• Strategic pivot and integration risks underexplained. The investor materials describe an aggressive strategic pivot from a Kathy‑Ireland–centric licensing business into a CBD‑focused consumer products company, but the deck does not clearly lay out integration milestones or transition risks from the legacy business, even though the ownership structure shifts control to the cbdMD side through the all‑stock reverse‑merger–like transaction.
• Shareholder dilution and governance impacts not front‑and‑center in the deck. The acquisition consideration is heavily stock‑based, including large tranches of shares and long‑dated earnout rights for cbdMD’s prior owners, yet the deck marketing narrative focuses more on growth upside than on potential dilution and governance implications for existing public shareholders; those details must be pieced together from the Merger Agreement and corporate updates rather than the slides.

How an investor would read this deck

What draws attention

• The deck represents a public‑company pivot story: a small, brand‑licensing issuer (tied to Kathy Ireland) is effectively transformed via reverse‑merger structure into a CBD‑focused consumer products company, with cbdMD’s shareholders ending up with about 60% ownership.
• The cbdMD acquisition is structured as an all‑stock deal granting contractual rights to roughly 15.5 million shares plus additional earnout potential, creating material dilution but aligning cbdMD management’s incentives with long‑term share performance.
• Investor communications stress cbdMD’s broad product portfolio and THC‑free, domestically sourced positioning at a time when the U.S. CBD market was projected to grow rapidly, which, if realized, could support significant top‑line expansion.
• The leadership and board slate highlighted in the deck blends consumer‑brand personalities (e.g., Kathy Ireland) with cbdMD executives and outside directors, signaling an attempt to combine marketing reach with operational CBD expertise.

Risks that stand out

• CBD products operate in a complex and evolving regulatory environment in the United States, and filings around this period acknowledge regulatory and legal uncertainties that could adversely affect cbdMD’s ability to market and sell its products.
• The all‑stock acquisition structure and earnout rights give cbdMD’s prior owners a majority economic interest, creating substantial dilution and potentially shifting control away from legacy Level Brands shareholders.
• Rapid hiring and expansion highlighted in contemporaneous coverage (e.g., scaling headcount from a few dozen employees to over 100 in a short period) raises execution and cost‑control risk if revenue growth does not keep pace.
• Filings after the transaction flag going‑concern and liquidity risks, indicating that despite topline growth, cbdMD faced ongoing funding and cash‑flow challenges.

Questions this deck invites

• How did cbdMD’s revenue, gross margin, and operating losses trend over fiscal 2018–2019, and how did these compare to the projections implied by the January 2019 deck’s growth narrative?
• What specific earnout conditions and vesting milestones govern the additional cbdMD share issuances, and how much dilution ultimately occurred relative to the initial 15.5 million‑share contractual rights disclosed?
• How did the company manage regulatory risk around CBD (e.g., FDA guidance, state‑level rules) following the hemp‑legalization developments in late 2018, and did any such regulatory changes materially affect the business after the deck was p
• What portion of cbdMD’s sales mix came from direct‑to‑consumer e‑commerce versus retail and wholesale distribution, and how did customer concentration or channel risk evolve post‑transaction?
• To what extent did the strategic pivot away from the legacy licensing business (Kathy Ireland–related operations) impact cash flow and profitability, and how were any legacy obligations or contracts handled during the transition to cbdMD, I

What founders can take from the Level Brands (later cbdMD, Inc., NYSE American: LEVB → YCBD) deck

• A publicly traded micro‑cap can effectively execute a strategic pivot through an all‑stock acquisition that gives the target’s owners majority control, using investor decks to reframe the equity story around the new business while relying on SEC filings for transaction specifics.
• Rebranding the corporate identity (from Level Brands to cbdMD, Inc.) to match the acquired core brand can clarify market positioning and investor messaging when a legacy business model (like licensing) becomes secondary.
• In highly regulated, fast‑growing categories such as CBD, investor materials that emphasize supply‑chain control (domestic sourcing, pesticide‑free processes, seed‑to‑sale) can help differentiate from commoditized or lower‑quality competitors.
• All‑stock deals with multi‑year earnout structures can align incentives between public shareholders and private sellers but also introduce prolonged dilution overhang that sophisticated investors will model carefully.
• Decks that focus on brand narrative and market opportunity while relegating detailed financials and risk factors to regulatory filings may be effective for storytelling but require investors to integrate multiple document types for a full underwriting view.
• Anchoring a CBD consumer brand to recognizable personalities and board members (such as Kathy Ireland and prominent nonprofit and media figures) is a strategic branding choice that may aid awareness but does not substitute for the operational rigor and capital needed to win in a competitive, regulat

Level Brands (later cbdMD, Inc., NYSE American: LEVB → YCBD) pitch deck: common questions

What was Level Brands and what did it become?

Level Brands was a Charlotte, North Carolina–based company that originally operated as a brand‑licensing platform associated with Kathy Ireland Worldwide and later transformed into a CBD consumer products company through its ownership of the cbdMD brand. In May 2019, after the cbdMD transaction, the company changed its name to cbdMD, Inc. and continued trading on the NYSE American under the ticker YCBD.

What transaction is highlighted in the January 2019 Level Brands investor deck?

The deck centers on Level Brands’ all‑stock acquisition of Cure Based Development, LLC, the owner of cbdMD. Under the December 3, 2018 Merger Agreement, members of Cure Based Development received contractual rights to up to about 15.5 million shares of Level Brands common stock—representing roughly 60% of the post‑transaction company—with the issuance split between an initial 6.5 million shares upon shareholder approval and additional tranches subject to vesting and earnout conditions over up to 60 months.

When did Level Brands change its name to cbdMD, Inc. and why?

According to Level Brands’ February 2019 corporate update and related filings, the company rebranded as cbdMD, Inc. shortly after the cbdMD acquisition closed, to reflect its strategic focus on CBD products. The name change followed the December 20, 2018 closing of the Cure Based Development / cbdMD merger.

What products and differentiation does cbdMD highlight in this investor deck?

The deck and related disclosures describe cbdMD’s products as including CBD gummies, tinctures, topicals, bath bombs, oils, and pet products, marketed as THC‑free or broad‑spectrum CBD offerings derived from domestically sourced hemp. The investor materials emphasize seed‑to‑sale control, 0% THC positioning, and domestically produced, pesticide‑free hemp inputs as differentiators versus lower‑quality imported CBD oils.

How was the cbdMD acquisition structured and what ownership did it confer?

In a December 2018 announcement and subsequent filings, Level Brands stated that the consideration for acquiring Cure Based Development / cbdMD consisted of up to approximately 15.5 million shares of Level Brands common stock, with an initial 6.5 million‑share tranche issued after shareholder approval and additional shares subject to vesting and earnout conditions. Separate disclosures noted that this all‑stock structure would increase Level Brands’ shares outstanding by roughly 150% and give Cure Based Development members about 60% ownership of the combined company.

Sources

Funding and outcome facts on this page were researched on 2026-08-22 from the pages below.

• Blueprint - SEC.gov
• Cure Based Development, LLC entered into a definitive agreement to acquire Level Brands, Inc. in a reverse merger transaction.
• cbdMD posts $16.2M sales but flags going concern risk | YCBD...
• LEVB Investor Deck January 2019
• Level Brands: Provides Corporate Update | MarketScreener
• Addendum No. 1 to Agreement and Plan of Merger dated March 31, 2021
• How This CBD Company Is Tackling A New Market: 'It's Important To Be First'
• RedChip Initiates Research Coverage on Level Brands (NYSE...

Level Brands (LEVB) pitch deck slides

What each slide of the Level Brands (LEVB) pitch deck says

Slide 2

Forward-looking Statements This presentation contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as "should," "may," "intends," "anticipates," "believes," "estimates," "projects," "forecasts," "expects," "plans," and "proposes." These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ…

Slide 3

Level Brands’ History » 2015: Founded as a consumer products company led by ly Kathy Ireland & Martin Sumichrast O \ eS » 2016: Expanded into licensing & brand management EY » November 2017: Completed IPO on NYSE American ay » December 2018: Completed transformational acquisition fl 7 of cbdMD % |. » cbdMD is an accelerating CBD company with premium A products currently available in 700 retail outlets in the US S L ER 18 L & through an expanding e-commerce channel SU = MC L > Our Goal: build cbdMD into the #1 CBD company aa 4

Slide 4

Powerful Brand Building & Executive Team LEADERSHIP TEAM Q Kathy Ireland kY Chief Brand Strategist & Chairman Emeritus Martin A. Sumichrast Chief Executive Officer & Chairman of the Board MarksS. Elliott Chief Financial Officer & Chief Operating Officer iy cbdMD TEAM Scott Coffman Founder & CEO Caryn Dunayer President BOARD OF DIRECTORS Anthony K. Shriver CEO of Best Buddies International Bakari Sellers Attorney, political analyst CNN, former member South Carolina House of Representatives Seymour Siegel President Siegel Rich, Inc. Gregory Morris Sr. Executive at Healthstat LB Level Brands

Slide 5

Innovative Licensing & Brand-Management Business Units » We provide instant brand recognition, creating kathy wreland bold, socially-responsible branding for leading HEALTH & WELLNESS businesses through our kathy ireland ® Health & he uss J Wellness and Ireland Men One (I'M 1) brands. l { M Bh » Our brand management business helps companies Ee develop strategies that create brand awareness, Ireland Men One access new markets, and sell products. | = B . ) AU » Consumer-products focused, targeting health & afm 0) 4) wellness, fashion, beauty, and entertainment. Encore Endeavor One = S = © CE) By

Slide 6

Powered by Nature. Enhanced by Science. | ar | = 7 . i cbdMD | 4 "ase = cbdMD is committed to the highest standards for CBD sourcing, extraction, and production. We offer a comprehensive line of 100% natural, hemp-derived CBD oil products, including tinctures, capsules, vape oils, bath bombs, topicals, and a full line of human-grade pet products. We pride ourselves on providing customers an all-natural alternative to traditional pharmaceuticals.

Slide 9

From Seed to Sale PRODUCT DEV > FORMULATION > MARKETING Start with organic, Extensive production Market CBD domesticallyprocess — from products for masses, sourced hemp seed to shelf not the few LB 9 Level Brands

Slide 10

The cbdMD Difference INNOVATIVE FANG D) GROWING ARE NOT bt COMMITMENT PROTECTED FROM EXIBACTION PESTICIDES TECHNIQUES LOW QUALITY HEMP LOCALLY GROWN OILIMPORTED LOCALLY MADE: e lor i) QUALITY FROM OVERSEAS . \ 0% THC "HYBRID" STANDARD CBD BROAD-SPECTRUM INNOVATION EXTRACTION, PRODUCTS WITH BENEFICIAL VALUABLE COMPOUNDS PROPERTIES — . o T - @) =< o CANNABINOIDS l 10 ZLevel Brands

Slide text above is read directly from the Level Brands (LEVB) deck PDF embedded on this page.

Related fundraising guides (24)

• Chptr Pitch Deck Teardown: Modernizing the $120B Death Industry for Digital Natives
• Bloom Community Pitch Deck Teardown: Scaling Niche Social Networks Through Event Flywheels
• Auki Labs Pitch Deck Teardown: A $13M Bet on Replacing GPS for the Spatial Metaverse
• Anja Health Pitch Deck Teardown: A Narrative-Led Approach to Cord Blood Banking
• AgomAb Therapeutics Pitch Deck Teardown: A Masterclass in Biotech Pipeline Visualization
• Hedra Pitch Deck Teardown: A $32M Series A Built on Capital-Efficient AI Research
• Moonlight Pitch Deck Teardown: A Community-First Approach to Remote Engineering
• RegioHelden Pitch Deck Teardown: A Masterclass in Local Marketing Unit Economics
• Sunnyside Pitch Deck Teardown: A Masterclass in Market Expansion via Habit Modification
• Include Pitch Deck Teardown: Scaling Smart City Infrastructure Through Global Distribution
• HMNC Brain Health Pitch Deck Teardown: A Precision Psychiatry Play for Depression
• Haystack Oncology Pitch Deck Teardown: A Masterclass in Pedigree-Driven Biotech Fundraising
• Goldcast Pitch Deck Teardown: Turning Virtual Events Into A High-Velocity B2B Revenue Engine
• Factorial Pitch Deck Teardown: A Narrative-Driven Series C Strategy for HR Tech
• EcoVadis Pitch Deck Teardown: A Masterclass in Growth-Stage Market Dominance
• Dalan Animal Health Pitch Deck Teardown: A $3.5M Seed for the First Honeybee Vaccine
• CMR Surgical Pitch Deck Teardown: A $600M Masterclass in Ecosystem-Led Medical Robotics
• Cellarity Pitch Deck Teardown: A $121M Series C Masterclass in Platform-First Biotech
• Bramble Energy Pitch Deck Teardown: Leveraging PCB Supply Chains for Hydrogen Fuel Cells
• Avo Pitch Deck Teardown: A B2B2C Strategy for Last-Mile Logistics Dominance
• api.video Pitch Deck Teardown: A Developer-First Approach to $12M Series A
• Friday Finance Pitch Deck Teardown: A $20M Series A Built on Aggregation and Social Proof
• 10KC Pitch Deck Teardown: A $56M Growth Round Built on Enterprise Social Proof
• Limetree Pitch Deck Teardown: A Case Study in Early-Stage Family Media Preservation

Decks from the same year (1)

• 2019 pitch deck examples

Decks from the same region (1)

• US pitch deck examples

Browse companies alphabetically (1)

• Pitch decks from companies starting with L

More pitch deck teardowns (16)

• Leonardo.ai Pitch Deck Teardown: A Product-First Showcase of Generative AI Traction
• Leoverse Pitch Deck Teardown: A Technical Deep Dive into VR Aerospace Training
• Lesaka Pitch Deck Teardown: Consolidating the Fragmented African Fintech Landscape
• lesskomplex Pitch Deck Teardown: Bridging the Gap Between Excel and Enterprise Systems
• Letsdoiter Pitch Deck Teardown: A 2012-Era Goal-Setting Social Network Prototype
• Lets works Pitch Deck Teardown: A Hyper-Local Freelance Marketplace for the Indian Economy
• Letter AI Pitch Deck Teardown: A Lean 8-Slide Series B Masterclass in Social Proof
• LEUK Pitch Deck Teardown: A Hyper-Local Lifestyle Aggregator Seeking Seed Funding
• Level Brands Pitch Deck Teardown: A Multi-Brand Licensing and Management Strategy
• Levels Pitch Deck Breakdown: Leveraging Social Proof and Waitlist Velocity for a Series A
• Level Therapy Pitch Deck Breakdown: A Minimalist B2B Mental Health Play
• Level up Pitch Deck Teardown: A B2B Sales Deck for a Central-Eastern European SDG Accelerator
• Jini Pitch Deck Teardown: A 2012 Vision for Context-Aware Sensor Fusion
• LEX Markets Pitch Deck Breakdown: Securitizing Commercial Real Estate via Single-Asset IPOs
• Lexop Pitch Deck Teardown: Digitizing the $2 Billion Legal Document Delivery Market
• Lexop Pitch Deck Breakdown: Digitizing the $2B Legal Document Delivery Market

Recently published pitch deck teardowns (12)

• Belezen Pitch Deck Teardown: A Three-Sided Marketplace Strategy for Brazilian Beauty
• Bear & Breakfast Pitch Deck Teardown: A Masterclass in Visual Narrative and Tone
• Beatstoc Pitch Deck Teardown: A Speculative Play on Fan-Driven Artist Royalties
• BergTec Associates Pitch Deck Teardown: Solving the Canadian SMB 'Investment Hole'
• BidAway Pitch Deck Teardown: Gamifying the $39 Billion Luxury Hotel Inventory Problem
• Bitdharma LLC Pitch Deck Teardown: A Crypto-Centric SMB Management Vision
• BioTime Pitch Deck Teardown: A Public Market Roadmap for Regenerative Medicine
• Bitspawn Esports Pitch Deck Teardown: Solving the 'Burned Player' Problem via Automation
• BitRush Pitch Deck Teardown: A Multi-Layered Crypto Ecosystem Play
• BioVie Pitch Deck Teardown: Targeting Advanced Liver Cirrhosis with Clinical Data
• Blockit Pitch Deck Teardown: Solving Healthcare Referrals with a Blockchain Trojan Horse
• BlueOS Pitch Deck Teardown: A Content Agency Deck Disguised as a Tech Startup

Fundraising library · Pitch deck examples · Investor directory · Founder database